PMS and menopause: new hope for 15 million women with few options.(Women's Health Update)(Advertisement)

Women suffering from PMS, peri, pre, menopausal, and post-menopausal discomforts have been left with few viable and safe alternatives following the shocking news that traditional hormone replacement therapy (HRT) may cause many of the diseases it was thought to prevent, such as breast cancer, heart disease, stroke, and dementia.

As if strategically timed, a new all-natural, nonprescription nutraceutical called Brevail[R] should come as welcome relief to these women. Brevail is comprised of plant-based, nutrient-like compounds called lignans that have demonstrated the ability to address symptoms of menstrual and menopausal symptoms, as well as breast and heart health. Brevail is currently being distributed nationwide, fueled by growing consumer awareness and demand of this exciting breakthrough in women's self-healthcare.

Rise and Fall of HRT

For 15 years Sidney Constien, of Malvern, PA, as well as 15 million women just like her relied on HRT to help take the edge off menstrual and menopausal discomforts. And, like Sidney--millions of women remained on HRT even after menopause under the widespread belief that the drugs prevented heart disease. Then, in the spring of 2002 she was diagnosed with breast cancer.

Just a few short months later on June 9th 2002, 15 million women on HRT awoke to their morning paper and broadcast news to learn that the risks of these drugs outweigh the rewards. The National Institutes of Health halted its study of estrogen plus progestin therapy because of evidence that it increased the risk of strokes, blood clots, heart disease, and most shockingly to Constien--breast cancer. The painful irony was that HRT was previously thought to prevent these ailments. Adding insult to injury, a European HRT study with one million female participants was also halted for the very same reasons, and included increased risk of dementia. Although she is cancer free after lumpectomy and radiation, Constien, now 66 has a new mission, "I want to get the word out because I have friends who are still on it."

Now What?

Once one of the most widely prescribed class of drugs worldwide, prescriptions for HRT drastically dropped in the months following this startling news of their adverse health consequences, from 15 million to 9 million, as women began to seek alternatives to traditional HRT.